http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101088451-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 2007-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101088451-B1
titleOfInvention Quinoline derivatives with 5-HT binding properties
abstract The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof:n n n Formula In n n n n n n n Wheren n n X is a bond, -CH 2 CH 2- , -CH = CH-, -CH 2 O-, -CH 2 NR-, -CH 2 S (O)-, CH 2 S (O) 2- , -O- , OCH 2 CH 2 S (O) 2- , -CH 2 NRCO-, -CH 2 NRCH 2- , , -NRS (O) 2 NR-, -NHCHR- or -NRS (O) 2- , X can be inserted in both directions of the compound of formula (I);n n n Y is a bond, -CHR- or -OCH 2 CH 2- ;n n n R is hydrogen or lower alkyl;n n n Ar 1 and Ar 2 are independently of each other aryl or 5- to 10-membered heteroaryl, lower alkyl, lower alkoxy, lower haloalkoxy, halogen, -CF 3 , -CH 2 OH, -CH 2 O-lower alkyl, 3- to 10-membered cycloalkyl, 5- to 10-membered heterocycloalkyl, -CH 2 O (CH 2 ) 2 O-lower alkyl, -S (O) 2 -lower alkyl, or -S (O) 2 NHR Optionally substituted.
priorityDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03037871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004004726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03037872-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468341615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415938243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID319251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466485599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468355413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468395503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468395455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466471611

Total number of triples: 47.